Literature DB >> 23377971

MicroRNAs in the lung.

Alexandra Sittka1, Bernd Schmeck.   

Abstract

The lung constitutes one of the most delicate tissue structures in mammalian organisms to accomplish the vital function of gas exchange. On the other hand, its immense surface area, necessary in this context, exhibits the first line of defense against a variety of pro-inflammatory stimuli.MicroRNAs (miRNAs) are a class of post-transcriptional regulators that revolutionized our view of gene expression regulation. By now, it is well established that miRNAs impair all known cellular and developmental processes. Extensive research over the last years revealed not only a fundamental role for miRNAs in lung development and homeostasis, but also in the process of lung inflammation. Lung inflammation occurs in response to stimuli very different in nature (e.g., physical, radioactive, infective, pro-allergenic, or toxic), and in some cases becomes manifest in chronic diseases (e.g., chronic bronchitis/chronic obstructive pulmonary disease (COPD), asthma and allergic airway diseases) or even lung cancer.This review chapter will briefly describe the current knowledge concerning miRNA expression and their exerted target regulation in the course of lung inflammation and lung cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377971     DOI: 10.1007/978-94-007-5590-1_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  Down-regulation of miR-452 is associated with poor prognosis in the non-small-cell lung cancer.

Authors:  Zhicheng He; Yang Xia; Bin Liu; Xiaotong Qi; Zhi Li; Jun Wang; Liang Chen; Yijiang Chen
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

Review 2.  Integrating omics technologies to study pulmonary physiology and pathology at the systems level.

Authors:  Ravi Ramesh Pathak; Vrushank Davé
Journal:  Cell Physiol Biochem       Date:  2014-04-28

Review 3.  MicroRNA as tools and therapeutics in lung cancer.

Authors:  Jennifer F Barger; S Patrick Nana-Sinkam
Journal:  Respir Med       Date:  2015-02-19       Impact factor: 3.415

4.  MiR-135b is a direct PAX6 target and specifies human neuroectoderm by inhibiting TGF-β/BMP signaling.

Authors:  Akshay Bhinge; Jeremie Poschmann; Seema C Namboori; Xianfeng Tian; Sharon Jia Hui Loh; Anna Traczyk; Shyam Prabhakar; Lawrence W Stanton
Journal:  EMBO J       Date:  2014-05-06       Impact factor: 11.598

5.  MiR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells.

Authors:  Haizhou Guo; Qianping Li; Weihao Li; Tianliang Zheng; Song Zhao; Zhangsuo Liu
Journal:  Mol Cell Biochem       Date:  2014-01-29       Impact factor: 3.396

6.  MiR-542-3p Suppresses Neuroblastoma Cell Proliferation and Invasion by Downregulation of KDM1A and ZNF346.

Authors:  Qiang Wei; Zhao Guo; Dong Chen; Xinjian Jia
Journal:  Open Life Sci       Date:  2020-04-10       Impact factor: 0.938

7.  A Semi-Supervised Learning Algorithm for Predicting Four Types MiRNA-Disease Associations by Mutual Information in a Heterogeneous Network.

Authors:  Xiaotian Zhang; Jian Yin; Xu Zhang
Journal:  Genes (Basel)       Date:  2018-03-02       Impact factor: 4.096

8.  miR-96 promotes invasion and metastasis by targeting GPC3 in non-small cell lung cancer cells.

Authors:  Xiubin Fei; Jingang Zhang; Yunwei Zhao; Meijia Sun; Haifeng Zhao; Shuang Li
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

9.  A modified protocol for successful miRNA profiling in human precision-cut lung slices (PCLS).

Authors:  Monika Niehof; Stella Marie Reamon-Buettner; Olga Danov; Tanja Hansen; Katherina Sewald
Journal:  BMC Res Notes       Date:  2021-07-02

Review 10.  MicroRNAs in lung cancer.

Authors:  Diana Castro; Márcia Moreira; Alexandra Monteiro Gouveia; Daniel Humberto Pozza; Ramon Andrade De Mello
Journal:  Oncotarget       Date:  2017-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.